Delcath Systems

IPO

Delcath

Public · New York, United States · Founded 1988 · $103.3M raised

Headquarters
New York, New York
Founded
1988
Business Model
B2B
Total Funding
$103.3M
Last Round
$16.3M Private EquityJan 2024
Rounds
5
Type
Public

About

Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. The company's proprietary products are HEPZATO KIT for Injection with the Hepatic Delivery System and CHEMOSAT Hepatic Delivery System for Melphalan percutaneous hepatic perfusion. Delcath delivers therapies through vascular isolation of the liver, focused delivery of therapy, and filtration of excess drug to improve clinical outcomes while reducing drug-related side effects.

Summary

Delcath Systems is a Biotech company based in New York, United States, founded in 1988. It has raised $103.3M in total across 5 rounds, most recently a $16.3M Private Equity round in Jan 2024. Investors include Fundamental Healthcare Investors, Healthcare Investors and Rosalind Advisors.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Private EquityPrivate EquityJan 2024
$16.3M

Sign up to see all 5 rounds

Private Equity — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Delcath Systems on Indexed.vc
<a href="https://indexed.vc/companies/delcath-systems"><img src="https://indexed.vc/api/badge/company/delcath-systems" alt="Delcath Systems on Indexed.vc" width="260" height="76" /></a>